Immunovant, Inc. (IMVT)
25.92
+0.28
(+1.09%)
USD |
NASDAQ |
Feb 13, 12:14
Immunovant EPS Diluted (Quarterly) : -0.6095 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Boston Scientific Corp. | 0.4493 |
| Revvity, Inc. | 0.8459 |
| Viridian Therapeutics, Inc. | -0.423 |
| Plus Therapeutics, Inc. | -0.0412 |
| Nutriband, Inc. | -0.3212 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -110.64M |
| Total Expenses (Quarterly) | 110.64M |
| Enterprise Value | 4.224B |
| Earnings Yield | -10.35% |
| Normalized Earnings Yield | -10.35 |